SMAD2 and skin squamous cell carcinoma: Overall, a reduction in endogenous PO4-SMAD2/3 levels were identified in cSCC tumours when compared to peri-lesional skin, supporting a tumour suppressor functional role for TGF-β/activin in squamous skin cancers.